These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29037366)

  • 1. Oral tolerance induction in allergy: Kissing awake a sleeping beauty.
    Valenta R
    Semin Immunol; 2017 Apr; 30():1-2. PubMed ID: 29037366
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral tolerance and allergy.
    Hamad A; Burks W
    Semin Immunol; 2017 Apr; 30():28-35. PubMed ID: 28739336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen immunotherapy.
    Mannan S
    Immunotherapy; 2017 Nov; 9(15):1199-1200. PubMed ID: 29130796
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of immunotherapy with individual allergens: Immunotherapy with fungi.
    Pineda F
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():36-38. PubMed ID: 29129403
    [No Abstract]   [Full Text] [Related]  

  • 5. Interventional Therapies for the Treatment of Food Allergy.
    Parrish CP; Kim EH; Bird JA
    Immunol Allergy Clin North Am; 2018 Feb; 38(1):77-88. PubMed ID: 29132676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The best allergen immunotherapy choice for mite allergic patients.
    Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
    Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
    Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
    Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA-approved peanut allergy treatment: The first wave is about to crest.
    Tilles SA; Petroni D
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):145-149. PubMed ID: 29909055
    [No Abstract]   [Full Text] [Related]  

  • 9. Epicutaneous immunotherapy.
    Scheurer S; Toda M
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():25-29. PubMed ID: 29108765
    [No Abstract]   [Full Text] [Related]  

  • 10. Food allergy in childhood: Are we close to having an effective treatment?
    Alvaro M; Escarrer M
    Allergol Immunopathol (Madr); 2017; 45(4):313-315. PubMed ID: 28688477
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in immunotherapy: the active treatment of food allergy on the horizon.
    Pajno GB; Caminiti L; Crisafulli G; Salzano G
    Expert Rev Clin Immunol; 2013 Oct; 9(10):891-3. PubMed ID: 24128153
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergy Immunotherapy: Are We Making Progress or Just Standing Still?
    Cox LS
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):xiii-xiv. PubMed ID: 31761125
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy with allergens.
    Creticos PS; Norman PS
    JAMA; 1987 Nov; 258(20):2874-80. PubMed ID: 3312669
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with T-cell-reactive peptides derived from allergens.
    Wallner BP; Gefter ML
    Allergy; 1994 May; 49(5):302-8. PubMed ID: 7522417
    [No Abstract]   [Full Text] [Related]  

  • 16. Requirements of a new allergen regulation.
    Rivas-Juesas C; Tomás Bartra J; Purroy Tabar AM
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():15-16. PubMed ID: 29132811
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral Tolerance Development and Maintenance.
    Wambre E; Jeong D
    Immunol Allergy Clin North Am; 2018 Feb; 38(1):27-37. PubMed ID: 29132672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is reliable in hyposensitization of IgE-induced diseases? Indications, contraindications, results and side effects].
    Fuchs T
    Internist (Berl); 1991 Dec; 32(12):721-8. PubMed ID: 1783514
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy.
    van de Veen W; Wirz OF; Globinska A; Akdis M
    Curr Opin Immunol; 2017 Oct; 48():74-81. PubMed ID: 28888176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy coming of age: notable advances during the first hundred years.
    Nelson HS
    Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.